Related Experiment Video
Updated: Oct 25, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.2K
Identification of Somatic Mutation-Driven Immune Cells by Integrating Genomic and Transcriptome Data
Ying Jiang1, Baotong Zheng2, Yang Yang2
1College of Basic Medical Science, Heilongjiang University of Chinese Medicine, Harbin, China.
Frontiers in Cell and Developmental Biology
|August 9, 2021
Summary
A new R-based software package, SMDIC, automates the identification of tumor-infiltrating immune cells driven by specific somatic mutations. This tool aids in understanding anticancer immune responses and identifying potential cancer immunotherapy targets.
Area of Science:
- Oncology
- Immunology
- Bioinformatics
Background:
- Somatic mutations in tumors can create neoantigens, potentially activating antitumor immune responses.
- Immune cell activity significantly impacts tumor progression, but tools for linking specific mutations to immune cells are lacking.
Purpose of the Study:
- To develop a computational method for systematically identifying tumor-infiltrating immune cells driven by specific somatic mutations in cancer.
- To provide a user-friendly tool for discovering mutation-specific immune cell responses.
Main Methods:
- Developed SMDIC, an R-based software package integrating genomic and transcriptome data.
- Implemented a pipeline for inferring immune cell abundance, detecting differential abundance based on mutation status, and identifying mutation-driven immune cells.
- Included visualization of immune cell abundance across different mutation statuses.
Main Results:
- SMDIC enables automated identification of somatic mutation-driven immune cells.
- The software facilitates the discovery of mutation-specific immune cell responses.
- Provides a means to visualize immune cell abundance relative to gene mutation status.
Conclusions:
- SMDIC is a novel, user-friendly tool for identifying somatic mutation-specific immune cell responses.
- This tool can advance the understanding of anticancer immunity mechanisms.
- SMDIC may help identify novel targets for cancer immunotherapy.

